Elevance Health, Inc. (BMV:ELV)

Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of MXN 1.24 trillion. The enterprise value is 1.64 trillion.

Market Cap	1.24T
Enterprise Value	1.64T

Important Dates

The last earnings date was Wednesday, January 28, 2026.

Earnings Date	Jan 28, 2026
Ex-Dividend Date	Dec 5, 2025

Share Statistics

Current Share Class	222.24M
Shares Outstanding	n/a
Shares Change (YoY)	-3.56%
Shares Change (QoQ)	-0.85%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	92.34%
Float	220.22M

Valuation Ratios

The trailing PE ratio is 12.15 and the forward PE ratio is 12.68.

PE Ratio	12.15
Forward PE	12.68
PS Ratio	0.35
PB Ratio	1.56
P/TBV Ratio	15.86
P/FCF Ratio	21.68
P/OCF Ratio	16.04
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.37, with an EV/FCF ratio of 28.74.

EV / Earnings	16.11
EV / Sales	0.48
EV / EBITDA	10.37
EV / EBIT	11.48
EV / FCF	28.74

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.74.

Current Ratio	1.54
Quick Ratio	1.41
Debt / Equity	0.74
Debt / EBITDA	3.57
Debt / FCF	10.32
Interest Coverage	5.91

Financial Efficiency

Return on equity (ROE) is 13.25% and return on invested capital (ROIC) is 9.16%.

Return on Equity (ROE)	13.25%
Return on Assets (ROA)	4.35%
Return on Invested Capital (ROIC)	9.16%
Return on Capital Employed (ROCE)	10.31%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	37.11M
Profits Per Employee	1.06M
Employee Count	97,100
Asset Turnover	1.67
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 18.89 billion in taxes.

Income Tax	18.89B
Effective Tax Rate	15.63%

Stock Price Statistics

The stock price has decreased by -26.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.81%
50-Day Moving Average	6,770.18
200-Day Moving Average	8,518.06
Relative Strength Index (RSI)	47.43
Average Volume (20 Days)	325

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.24

Income Statement

In the last 12 months, Elevance Health had revenue of MXN 3.58 trillion and earned 101.93 billion in profits. Earnings per share was 453.86.

Revenue	3.58T
Gross Profit	916.42B
Operating Income	149.37B
Pretax Income	120.80B
Net Income	101.93B
EBITDA	162.75B
EBIT	149.37B
Earnings Per Share (EPS)	453.86

Balance Sheet

The company has 650.19 billion in cash and 589.60 billion in debt, with a net cash position of -418.74 billion.

Cash & Cash Equivalents	650.19B
Total Debt	589.60B
Net Cash	-418.74B
Net Cash Per Share	n/a
Equity (Book Value)	792.61B
Book Value Per Share	3,579.21
Working Capital	395.46B

Cash Flow

In the last 12 months, operating cash flow was 77.23 billion and capital expenditures -20.09 billion, giving a free cash flow of 57.14 billion.

Operating Cash Flow	77.23B
Capital Expenditures	-20.09B
Free Cash Flow	57.14B
FCF Per Share	n/a

Margins

Gross margin is 25.56%, with operating and profit margins of 4.17% and 2.84%.

Gross Margin	25.56%
Operating Margin	4.17%
Pretax Margin	3.37%
Profit Margin	2.84%
EBITDA Margin	4.54%
EBIT Margin	4.17%
FCF Margin	1.59%

Dividends & Yields

This stock pays an annual dividend of 130.32, which amounts to a dividend yield of 2.16%.

Dividend Per Share	130.32
Dividend Yield	2.16%
Dividend Growth (YoY)	6.13%
Years of Dividend Growth	14
Payout Ratio	27.00%
Buyback Yield	3.56%
Shareholder Yield	5.72%
Earnings Yield	8.23%
FCF Yield	4.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5